{"disease":{"id":"post-transplant-diabetes-mellitus","name":"post transplant diabetes mellitus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06440330","title":"Define Predictors for Posttransplant Diabetes Mellitus Study","phase":"","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT06801886","title":"Silymarin's Advantage on Graft Effectiveness","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":130,"lead_sponsor_name":"University Hospital, Martin","has_results":false},{"nct_id":"NCT05240274","title":"The POWERED Study: Prophylaxis With Metformin to Prevent PTDM","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT04965935","title":"Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05396898","title":"Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT03113110","title":"Empagliflozin in Post-Transplantation Diabetes Mellitus","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Medical University of Vienna","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}